Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Paxil
|
| gptkbp:approves |
gptkb:2001
|
| gptkbp:brand |
gptkb:Paxil
|
| gptkbp:code |
N06 AB
|
| gptkbp:contraindication |
liver disease
pregnancy MAO inhibitors |
| gptkbp:dosage_form |
film-coated tablet
|
| gptkbp:excretion |
urine
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:has_ability |
10 mg
20 mg 30 mg |
| https://www.w3.org/2000/01/rdf-schema#label |
Pexeva
|
| gptkbp:ingredients |
gptkb:paroxetine
|
| gptkbp:interacts_with |
gptkb:warfarin
NSAI Ds other SSR Is |
| gptkbp:is_used_for |
social anxiety disorder
generalized anxiety disorder obsessive-compulsive disorder major depressive disorder panic disorder |
| gptkbp:legal_issue |
prescription only
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:metabolism |
liver
|
| gptkbp:packaging |
blister pack
|
| gptkbp:pharmacokinetics |
half-life 24 hours
|
| gptkbp:side_effect |
dizziness
nausea insomnia dry mouth sexual dysfunction |
| gptkbp:type_of |
57317-64-1
|